Personal profile
Fingerprint
Dive into the research topics where Mitsuo Nagasaka is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Clinical Outcomes of Reduced-Dose Cabozantinib as Third- or Later-Line Therapy After Immune Checkpoint Inhibitors in Advanced Hepatocellular Carcinoma: A Real-World Study
Kuzuya, T., Muto, H., Tachi, Y., Ariga, M., Morisaki, S., Komura, G., Nakano, T., Tanaka, H., Nakaoka, K., Ohno, E., Funasaka, K., Nagasaka, M., Miyahara, R. & Hirooka, Y., 04-2026, In: Hepatology Research. 56, 4, p. 538-549 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Efficacy of Second-line Lenvatinib for Hepatocellular Carcinoma After Early Progression on Atezolizumab-Bevacizumab
MUTO, H., KUZUYA, T., TACHI, Y., NAGANO, Y., KAJINO, Y., MATSUSHITA, M., HAGIHARA, S., YAMAMOTO, S., KOBAYASHI, T., KATANO, Y., OHMIYA, N., HASHIMOTO, S., ARIGA, M., MORISAKI, S., KOMURA, G., NAKANO, T., TANAKA, H., NAKAOKA, K., OHNO, E. & FUNASAKA, K. & 3 others, , 03-2026, In: Anticancer research. 46, 3, p. 1609-1618 10 p.Research output: Contribution to journal › Article › peer-review
-
The Central Role of Liver Function at Treatment Initiation and Its Preservation at Progression for Post-Progression Survival After Atezolizumab Plus Bevacizumab in Advanced Hepatocellular Carcinoma
Ariga, M., Kuzuya, T., Muto, H., Tachi, Y., Kobayashi, M., Sugiyama, H., Morisaki, S., Komura, G., Nakano, T., Tanaka, H., Nakaoka, K., Ohno, E., Funasaka, K., Nagasaka, M., Miyahara, R. & Hirooka, Y., 01-2026, In: Biomedicines. 14, 1, 232.Research output: Contribution to journal › Article › peer-review
Open Access -
Biomarker-Based Responder Selection and Early Prediction of Treatment Response in Hepatocellular Carcinoma: Dynamic Changes in Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin During Atezolizumab Plus Bevacizumab Therapy
Kuzuya, T., Muto, H., Tachi, Y., Kobayashi, M., Sugiyama, H., Ariga, M., Morisaki, S., Komura, G., Nakano, T., Tanaka, H., Nakaoka, K., Ohno, E., Funasaka, K., Nagasaka, M., Miyahara, R. & Hirooka, Y., 12-2025, In: Cancers. 17, 24, 3891.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Post Hoc Analysis of Anxiety and Behavioral Changes in Japanese Patients With Inflammatory Bowel Disease due to the COVID-19 Pandemic: Relationship Between Municipal Population at the Place of Residence and Anxiety
J-DESIRE Group, 07-2025, In: JGH Open. 9, 7, e70209.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus)